Background. Multiplex real-time polymerase chain reaction respiratory viral panel (RVP) testing offers enhanced test performance characteristics compared with older testing methods. However, the impact of RVP testing on physician antimicrobial prescription practices remains unclear. Our objective was to assess the potential relationship of RVP testing to physician treatment practices for children hospitalized with acute respiratory illness (ARI). Methods. We performed a retrospective chart review of children hospitalized for ARI during peak prevalence of respiratory viral infections in 2009-2011. Demographics, diagnostic testing, antimicrobial use, and clinical outcomes were abstracted from the electronic medical record. Antimicrobial use was compared with RVP testing data. Results. A total of 1727 patients met inclusion criteria. Of these patients, 254 (14.7%) children who were hospitalized for ARI received oseltamivir and 856 (49.6%) children received antibiotics. More children who received oseltamivir were positive for influenza by RVP (76.9% vs 18.0%; P < .0001). Children who underwent RVP testing received antibiotics more often than those who were not tested (53.7% vs 46.0%; P = .001), but children with a positive RVP test result received antibiotics less often (51.6% vs 67.0%; P = .003). A total of 5.8% of children who were positive for a viral pathogen by RVP had antibiotics discontinued. Antibiotics were started in fewer children when RVP results were positive (10.9% vs 100.0%; P < .0001). Conclusions. Respiratory viral panel testing was associated with more appropriate oseltamivir use in children hospitalized with ARI. Physicians started antibiotics more often in children with a negative RVP test result and occasionally discontinued antibiotics in children diagnosed with a viral pathogen. These results suggest that RVP testing may enhance physician decision-making when prescribing antimicrobials in children hospitalized with ARI.
children, particularly in children under 5 years of age [9] [10] . Despite this result, many children receive empiric courses of antibiotics [11] [12] [13] , and indications for antiviral prescribing are often not clear cut [14] . Thus, accurate and timely virologic diagnosis may improve healthcare quality by optimizing physician antimicrobial prescription practices.
Multiplex real-time polymerase chain reaction (RT-PCR) testing for respiratory viral pathogens provides enhanced sensitivity, specificity, and increased number of pathogens assayed in a single assay compared with older diagnostic methodologies (Table 1) [15] [16] . Given the relatively poor negative predictive value of viral culture and rapid antigen tests, studies assessing the impact of such older diagnostic methods on physician antimicrobial prescription practices have demonstrated variable utility [17] [18] [19] [20] . Although a few studies have examined the potential utility of multiplex RT-PCR testing in improving physician antimicrobial prescription practices [21] [22] , data are limited in regards to hospitalized children. Only 1 study has been published that assessed the impact of multiplex RT-PCR viral testing on antibiotic prescription practices for hospitalized children, and it showed no change in diagnostic testing, length of stay, or antimicrobial use [23] . Data on antiviral prescription practices are generally lacking.
In 2009, the Lifespan network microbiology laboratory implemented the xTAG multiplex RT-PCR respiratory viral panel (RVP) (Luminex, Austin, TX) assay to aid in diagnosis and management of patients hospitalized with ARI during pandemic 2009-2010 influenza A H1N1. The assay is capable of detecting 14 different respiratory pathogens (Table 1) , and the average turn-around time (TAT) is 20 hours (range, 6-30 hours) for the Lifespan laboratory. The xTAG RVP assay has been in use every respiratory viral season since 2009. The objective of this study is to assess the potential relationship of RVP testing to physician antimicrobial prescription practices for children hospitalized with ARI. We hypothesized that children hospitalized with ARI and undergoing RVP testing would have had the following: (1) antibiotics stopped more often after a positive RVP test result was available compared to those with a negative test result; (2) lower antibiotic prescription rates than those not undergoing RVP testing; (3) higher rates of antibiotic use when RVP results were negative; (4) higher rates of oseltamivir therapy when RVP testing was positive for influenza; (5) lower oseltamivir use after a negative RVP test result; and (6) lower rates of antibiotic initiation after a positive RVP test result than those children who have a negative RVP test result.
METHODS

Chart Selection
Reviewers abstracted information from the electronic medical records of (EMRs) children aged 0-18 years hospitalized at Hasbro Children's Hospital of Rhode Island Hospital during the highest incidence months for respira- Charts from children hospitalized with a diagnosis of ARI were eligible for data abstraction. Acute respiratory illness was determined based on an International Classification of Diseases, 9th edition (ICD-9) discharge diagnosis code for any of the following: pneumonia (480-488); acute nasopharyngitis (460); pharyngitis (462); laryngitis or tracheitis (464.0, 464.3, 464.4); upper respiratory infection (465); or bronchiolitis (466). All eligible children were included in the analyses: for children with multiple hospitalizations during a given respiratory viral season, only data from the first admission were obtained.
During the time period of chart review, the RVP was available (1) for physician use in hospitalized patients based on physician preference and (2) for any diagnosis in which the physician considered it potentially beneficial, including ARI. During the study period, there was no physiciandriven antimicrobial stewardship program in place at Hasbro Children's Hospital. However, guidance for use of the RVP was provided to healthcare providers during each study period by the microbiology department through multiple outreach meetings, e-mailed notices, and literature made available on the hospital's internal website.
Clinical Information
Demographics, diagnostic testing, antimicrobial use, and clinical outcomes were abstracted from the EMR. Children with chronic medical conditions, as defined by ICD-9 code, were identified based on previously described methods [24] . Bacteriologic testing was determined positive for a pathogen if the result was flagged as abnormal in the EMR by the pathology reporting system and subsequently confirmed by manual chart review. In particular, blood cultures were considered positive for a pathogen if noncontaminant bacterial species (eg, Staphylococcus aureus, Escherichia coli, Group B streptococci, etc) were isolated or, in the case of bacteria that are common skin contaminants, if the isolate was treated as true bacteremia by the primary medical team. Urine cultures that grew a single organism, either >10 000 colony-forming units (cfu)/mL in the case of catheter specimens or >100 000 cfu/mL from a clean-catch specimen, were considered positive for urinary tract infection if the accompanying urinalyses were positive for pyuria, nitrites, or leukocyte esterase. Sputum cultures were considered positive if there were less than 10 squamous cells per high-powered field in the sample, more than 25 polymorphonuclear cells per high-powered field, and the culture grew a predominating organism. Induced sputum and deep respiratory aspiration specimens were also assessed for appropriateness for specimen culture as noted above. Chest radiography results were classified as abnormal/possible pneumonia based on manual review of signed radiology reports, which included a clinical impression of focal infiltrate, multifocal infiltrate, or insterstitial infiltrate and included only chest X-rays obtained on the day of admission. Respiratory viral panel testing was conducted at our facility using the Luminex xTAG RVP. Respiratory viral panel test order date and time and result date and time were obtained for comparison with antimicrobial administration data. Antimicrobial agents used, as well as their start and stop dates and times, were obtained from abstraction of the inpatient pharmacy medication administration database.
Statistical Analysis
Rates of antimicrobial use were compared with RVP testing data. 
RESULTS
A total of 1727 patient records met inclusion criteria. Demographic, discharge diagnosis, diagnostic testing, and antimicrobial prescription data based on whether patients underwent RVP testing are listed in RVP Testing and ARI Management 149 age and season revealed that patients prescribed oseltamivir during the subsequent nonpandemic season were comparatively older (OR, 2.19; P = .021).
DISCUSSION
Our retrospective review of children hospitalized during 2 respiratory viral seasons revealed a significant association with RVP testing and antimicrobial use. In terms of oseltamivir use, we found that children who were tested for influenza by RVP were prescribed oseltamivir more frequently than those children who were not undergoing viral testing. This treatment is understandable given a likely higher pretest probability for influenza infection among tested children. More importantly, physicians more frequently prescribed oseltamivir in children found to be positive for influenza by RVP. This treatment represented a combination of initiation of oseltamivir in patients at or near hospital admission as well as patients subsequently found to be positive for influenza. Although researchers in previous studies have examined in part the potential relationship between antiviral prescription practices and diagnostic testing for influenza [17, 25] , we believe our study is the first to find an association between more accurate oseltamivir use and RT-PCR respiratory viral testing in hospitalized children. It is of interest to note that only 38% of patients had oseltamivir discontinued despite a negative PCR influenza result. In multiple regression analysis, abnormal white blood cell count (WBC) was significantly associated with odds of discontinuing oseltamivir (OR, .32; P = .048), but other factors, including influenza test result (OR, .50, P = .064) and length of hospital stay (OR, .58; P = .066),
were not associated with oseltamivir discontinuation, although a trend toward discontinuation could be discerned.
The lack of significant association may be due in part to the TAT of the RVP of 20 hours (range, 6-30) and highlights the need for prospective study of the impact of a more rapid PCR influenza result on oseltamivir use in hospitalized children, particularly given that US Food and Drug Administration (FDA)-cleared rapid molecular assays exist. Our data also revealed a large proportion of positive RVP test results among children who were tested. This finding is not surprising given that most cases of ARI in children are virally mediated [9] [10] . In addition, we found that influenza-positive test results composed only 21.8% of positive results during the 2009-2010 season and 7.5% during the 2010-2011 season. These results support previously reported measurements of pandemic and nonpandemic influenza prevalence rates and the presence of many viral entities simultaneously [26] [27] [28] [29] . These data highlight the need for accurate diagnosis of influenza among hospitalized children receiving oseltamivir, because empiric use may not be cost-effective depending on disease prevalence [30] , and reducing unnecessary use would decrease exposure of patients to avoidable medication side effects [31] .
Diagnosis of a respiratory viral pathogen in our study was also associated with a decreased OR of being prescribed antibiotics in univariate analysis, but not in multiple regression analysis. The latter may have been because multiple potential confounders, including presence of AOM and bacterial testing, were taken into account in multiple regression analysis. In addition, a small number of children had antibiotics discontinued within 24 hours after positive RVP test results. In comparison to our data, we were only able to identify one study of RT-PCR-based testing performed in hospitalized children, but it showed no correlation between RVP testing and antimicrobial prescription practices [23] . However, baseline antibiotic use was much higher in the intervention arm of the study by Wishaupt et al [23] , and rates of discontinuation were not measured. The results we found in our study are similar to those of Wishaupt et al [23] , however, in terms of antibiotic duration, with mean days on antibiotics not differing between children based on RVP test result (5.15 ± 2.97 days RVP positive vs 5.19 ± 2.93 days RVP negative; P = .92). Previous studies of antibiotic use in children seen in emergency departments for ARI that involved direct fluorescence antibody (DFA)-based influenza testing showed no difference in rates of antibiotic use in children who tested positive [17] , but DFA testing is much less sensitive than RT-PCR-based methods and with a much more limited spectrum of common viral pathogens that it can detect from a single specimen. Such diagnostic uncertainty associated with other testing methods could lead to overprescription of antibiotics by physicians uncertain of the underlying etiology of a child's illness. Finally, RT-PCR methods can provide results with much greater speed than cell-culture modalities, which take up to 14 days. A possible reason that a significant proportion of our children undergoing RVP testing, including those positive for a viral pathogen, received antibiotics may be the concern for viral or bacterial coinfection. Results in our study showed that a significant proportion of children undergoing sputum culture and RVP testing had both bacterial and viral pathogens identified. This finding is not surprising based on previously published data. For example, influenza coinfection can occur in up to 3% of children hospitalized for complicated bacterial pneumonia [32] , and viral or bacterial coinfection may occur in as many as 23% of children with radiographically evident LRTI [33] . However, methods of diagnosing bacterial pneumonia in children remain limited, and viral LRTI remains the most common cause of community-acquired pneumonia in children [34] . The perceived limited value of bacterial testing was evident in our study given that only 7.7% of patients assessed had both viral and bacterial studies performed. This observation means that, although RVP testing may be a reliable method of diagnosing a viral infection, it cannot exclude a concomitant bacterial pneumonia. A recent FDA-cleared assay (BioFire, Respiratory Panel Assay) that detects both viruses and 3 common bacterial pathogens may provide this reliability, but no clinical outcome data exist to date. Thus, determination of a dual viral and bacterial infection primarily relies on clinical evaluation and general laboratory testing. The use of inflammatory biomarkers such as procalcitonin is being increasingly evaluated, and its use is suggested as a decision aid for antibiotic discontinuation in ARI [35] . Therefore, a combination of virologic testing and inflammatory biomarkers may be a potential strategy to fully optimize antibiotic use in children hospitalized with ARI. Finally, the 20-hour TAT of the RVP may have meant that, in children with ARI warranting admission, physicians preferred to empirically treat a possible pneumonia or serious bacterial infection pending RVP test results rather than risk the patient's clinical status worsening. This practice further highlights the need for more rapid multiplex virologic testing and/or bacterial and viral testing.
There are several limitations to our study. First, we used retrospective data gathered primarily through use of discharge diagnosis codes. However, this method has been demonstrated to achieve reliable case-finding in previous studies of pneumonia [36] . In addition, we relied on written reports of chest radiography results and did not have all images reviewed by the same radiologist. However, the data we obtained from the reports were identical to what would have been seen by the treating pediatrician, who likely would have relied at least in part on the written report when making antimicrobial prescription decisions. Physicians also ordered the RVP test based on individual preference and practice pattern and not a clinical practice guideline. This procedure represents an unmeasurable bias in the population of patients undergoing RVP testing and could obscure potential effects of testing decisions or test results on antimicrobial prescription practices. In addition, the RVP assay used during this study period does not detect all possible viral pathogens, including parainfluenza virus IV, bocavirus, and coronaviruses, which could contribute to physician uncertainty regarding the reliability of a negative test result and would represent a population of patients in which actionable data could not be obtained. Finally, we were unable to assess antibiotic or oseltamivir use prior to admission, which could have affected duration and types of antimicrobial therapy prescribed during the patient's hospitalization.
The results of this study confirmed our hypotheses that children undergoing RVP testing would have higher rates of antibiotic use when RVP results were negative, higher rates of anti-influenza therapy when RVP testing was positive for influenza, antibiotics stopped more often after a positive RVP test result was available than those with a negative test result, and lower rates of antibiotic initiation after a positive RVP test result than those children who have a negative RVP test result. However, children undergoing RVP testing had a higher rate of antibiotic use than those who were not tested, and oseltamivir was not discontinued more often in children with a negative RVP influenza test result. In addition, antibiotic use was found to be associated with RVP test results in univariate analysis, but this association was not seen when controlling for potential confounding factors. These data highlight the need for future prospective studies to further assess the potential utility of multiplex RT-PCR respiratory viral testing as part of a comprehensive antimicrobial stewardship program in children's hospitals in conjunction with provider education efforts on the performance parameters of highly sensitive testing methods.
CONCLUSIONS
Respiratory viral panel testing was associated with more appropriate oseltamivir use in children hospitalized with ARI. Physicians more often started antibiotics in children with a negative RVP test result and occasionally discontinued antibiotics in children diagnosed with a viral pathogen. These results suggest that RVP testing may enhance physician decision-making when prescribing antimicrobials in children hospitalized with ARI.
